Amneal Pharmaceuticals (AMRX) Goodwill & Intangibles (2017 - 2026)

Amneal Pharmaceuticals' Goodwill & Intangibles history runs 10 years deep, the most recent figure standing at $1.1 billion for Q1 2026.

• In Q1 2026, Goodwill & Intangibles fell 12.28% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $1.1 billion (down 12.28% YoY), while the FY2025 annual figure was $1.2 billion, down 12.85% from the prior year.
• Goodwill & Intangibles for Q1 2026 stood at $1.1 billion, down from $1.2 billion in the prior quarter.
• The five-year high for Goodwill & Intangibles was $1.8 billion in Q1 2022, with the low at $1.1 billion in Q1 2026.
• The 5-year median for Goodwill & Intangibles is $1.5 billion (2024), against an average of $1.5 billion.
• The sharpest annual moves came in 2022 and 2025: Goodwill & Intangibles gained 1.51% in 2022, then decreased 14.12% in 2025.
• Amneal Pharmaceuticals' Goodwill & Intangibles stood at $1.7 billion in 2022, then retreated by 12.15% to $1.5 billion in 2023, then slipped by 10.69% to $1.3 billion in 2024, then fell by 12.85% to $1.2 billion in 2025, then fell by 2.61% to $1.1 billion in 2026.
• Business Quant data shows AMRX's Goodwill & Intangibles at $1.1 billion in Q1 2026, $1.2 billion in Q4 2025, and $1.2 billion in Q3 2025.